366 related articles for article (PubMed ID: 19453963)
1. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.
Younger J; Mackey S
Pain Med; 2009; 10(4):663-72. PubMed ID: 19453963
[TBL] [Abstract][Full Text] [Related]
2. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Younger J; Noor N; McCue R; Mackey S
Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
[TBL] [Abstract][Full Text] [Related]
3. The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
Patten DK; Schultz BG; Berlau DJ
Pharmacotherapy; 2018 Mar; 38(3):382-389. PubMed ID: 29377216
[TBL] [Abstract][Full Text] [Related]
4. Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.
Younger JW; Zautra AJ; Cummins ET
PLoS One; 2009; 4(4):e5180. PubMed ID: 19365548
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
[TBL] [Abstract][Full Text] [Related]
6. Low Dose Naltrexone in the Treatment of Fibromyalgia.
Metyas S; Chen CL; Yeter K; Solyman J; Arkfeld DG
Curr Rheumatol Rev; 2018; 14(2):177-180. PubMed ID: 28325149
[TBL] [Abstract][Full Text] [Related]
7. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
Staud R; Lucas YE; Price DD; Robinson ME
J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
[TBL] [Abstract][Full Text] [Related]
8. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
Hamann S; Sloan P
J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
[TBL] [Abstract][Full Text] [Related]
9. The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia.
Cote B; Ross B; Fortner J; Rao D
Int J Pharm Compd; 2018; 22(3):252-256. PubMed ID: 29878893
[TBL] [Abstract][Full Text] [Related]
10. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?
Ramanathan S; Panksepp J; Johnson B
Psychosomatics; 2012; 53(6):591-4. PubMed ID: 22480625
[No Abstract] [Full Text] [Related]
11. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.
Bruun KD; Amris K; Vaegter HB; Blichfeldt-Eckhardt MR; Holsgaard-Larsen A; Christensen R; Toft P
Trials; 2021 Nov; 22(1):804. PubMed ID: 34781989
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
Kim PS; Fishman MA
Curr Pain Headache Rep; 2020 Aug; 24(10):64. PubMed ID: 32845365
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Naltrexone for the Treatment of Fibromyalgia: Investigation of Dose-Response Relationships.
Bruun-Plesner K; Blichfeldt-Eckhardt MR; Vaegter HB; Lauridsen JT; Amris K; Toft P
Pain Med; 2020 Oct; 21(10):2253-2261. PubMed ID: 32068870
[TBL] [Abstract][Full Text] [Related]
14. [Low dose naltrexone for treatment of pain].
Plesner KB; Vægter HB; Handberg G
Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
[TBL] [Abstract][Full Text] [Related]
15. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
Pereira MP; Werner MU; Dahl JB
Trials; 2015 Nov; 16():511. PubMed ID: 26554360
[TBL] [Abstract][Full Text] [Related]
16. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
[TBL] [Abstract][Full Text] [Related]
17. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
Setnik B; Roland CL; Goli V; Sommerville K; Webster L
J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
[TBL] [Abstract][Full Text] [Related]
18. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study.
Staud R; Nagel S; Robinson ME; Price DD
Pain; 2009 Sep; 145(1-2):96-104. PubMed ID: 19540671
[TBL] [Abstract][Full Text] [Related]
19. Fibromyalgia.
Johnson J; Sheth S
J Pain Palliat Care Pharmacother; 2016 Sep; 30(3):233-4. PubMed ID: 27636677
[TBL] [Abstract][Full Text] [Related]
20. Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.
Largent-Milnes TM; Guo W; Wang HY; Burns LH; Vanderah TW
J Pain; 2008 Aug; 9(8):700-13. PubMed ID: 18468954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
